Similar articles

• Purine nucleoside phosphorylase deficiency: biochemical properties and heterogeneity in two families.

  Wortmann RL, Andres C, Kaminska J, Mejias E, Gelfand E, Arnold W, Rich K, Fox IH. Wortmann RL, et al. Arthritis Rheum. 1979 May;22(5):524-31. doi: 10.1002/art.1780220513. Arthritis Rheum. 1979. PMID: 36100
• Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.

  Edwards NL, Gelfand EW, Biggar D, Fox IH. Edwards NL, et al. J Lab Clin Med. 1978 May;91(5):736-49. J Lab Clin Med. 1978. PMID: 417142 No abstract available.
• Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean.

  Giblett ER. Giblett ER. Ciba Found Symp. 1978;(68):3-18. doi: 10.1002/9780470720516.ch2. Ciba Found Symp. 1978. PMID: 115664 Review. No abstract available.
• Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots.

  la Marca G, Canessa C, Giocaliere E, Romano F, Malvagia S, Funghini S, Moriondo M, Valleriani C, Lippi F, Ombrone D, Della Bona ML, Speckmann C, Borte S, Brodszki N, Gennery AR, Weinacht K, Celmeli F, Pagel J, de Martino M, Guerrini R, Wittkowski H, Santisteban I, Bali P, Ikinciogullari A, Hershfield M, Notarangelo LD, Resti M, Azzari C. la Marca G, et al. J Allergy Clin Immunol. 2014 Jul;134(1):155-9. doi: 10.1016/j.jaci.2014.01.040. Epub 2014 Apr 24. J Allergy Clin Immunol. 2014. PMID: 24767876
• Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.

  Carson DA, Kaye J. Carson DA, et al. Ciba Found Symp. 1978;(68):115-33. doi: 10.1002/9780470720516.ch8. Ciba Found Symp. 1978. PMID: 115660 Review.